- Home
- BNTX vs SBAC Comparison
BNTX vs SBAC Comparison
Compare BNTX & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- SBAC
- Stock Information
- Founded
- BNTX 2008
- SBAC 1989
- Country
- BNTX Germany
- SBAC United States
- Employees
- BNTX N/A
- SBAC N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- SBAC Real Estate Investment Trusts
- Sector
- BNTX Health Care
- SBAC Real Estate
- Exchange
- BNTX Nasdaq
- SBAC Nasdaq
- Market Cap
- BNTX 23.9B
- SBAC 24.0B
- IPO Year
- BNTX 2019
- SBAC 1999
- Fundamental
- Price
- BNTX $114.00
- SBAC $201.80
- Analyst Decision
- BNTX Strong Buy
- SBAC Buy
- Analyst Count
- BNTX 15
- SBAC 14
- Target Price
- BNTX $143.50
- SBAC $254.93
- AVG Volume (30 Days)
- BNTX 659.5K
- SBAC 903.1K
- Earning Date
- BNTX 11-04-2024
- SBAC 02-24-2025
- Dividend Yield
- BNTX N/A
- SBAC 1.94%
- EPS Growth
- BNTX N/A
- SBAC 39.29
- EPS
- BNTX N/A
- SBAC 6.34
- Revenue
- BNTX $3,390,698,192.00
- SBAC $2,660,958,000.00
- Revenue This Year
- BNTX N/A
- SBAC N/A
- Revenue Next Year
- BNTX N/A
- SBAC $2.90
- P/E Ratio
- BNTX N/A
- SBAC $31.97
- Revenue Growth
- BNTX N/A
- SBAC N/A
- 52 Week Low
- BNTX $76.53
- SBAC $183.64
- 52 Week High
- BNTX $131.49
- SBAC $256.68
- Technical
- Relative Strength Index (RSI)
- BNTX 48.71
- SBAC 29.93
- Support Level
- BNTX $109.52
- SBAC $197.16
- Resistance Level
- BNTX $115.34
- SBAC $204.58
- Average True Range (ATR)
- BNTX 4.24
- SBAC 4.27
- MACD
- BNTX -0.72
- SBAC -1.08
- Stochastic Oscillator
- BNTX 27.24
- SBAC 16.86
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About SBAC SBA Communications Corporation
SBA Communications owns and operates almost 40,000 cell towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. It owns more than 17,000 towers in the US, which accounted for about 70% of the company's total revenue in 2023. Internationally, SBA's greatest presence is in Brazil, where it operates roughly 10,000 towers. SBA operates as a real estate investment trust.